Oral drug shows promise for treating Barth syndrome
24 July, 2025An oral drug called MA-5 can improve both heart and muscle problems in Barth syndrome, a rare genetic disorder affecting one in 300,000 births worldwide.
Novel drug candidates found for nerve pain and ischemic disease
09 July, 2025The discovery paves the way for potential new treatments for health conditions linked to tissue stress and inflammation, without accompanying side effects.
Biomaterial helps to reverse aging in the heart
24 June, 2025The discovery could open the door to therapies that rejuvenate the heart by changing its cellular environment, rather than the heart cells themselves.
Anti-inflammatory agent could decrease septic shock mortality
20 June, 2025Researchers have discovered a naturally occurring blood protein — a type of corticosteroid-binding globulin (CBG) — that could significantly decrease mortality caused by septic shock.
mRNA used to force HIV out of hiding
17 June, 2025Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to deliver mRNA to the elusive HIV reservoir and coax HIV out of hiding.
TGA approves therapy for paediatric growth hormone deficiency
11 June, 2025The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged from 3–18 years due to insufficient endogenous growth hormone secretion.
WMFTS WMArchitect Interchangeable Parts service for single-use assemblies
10 June, 2025Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.
Contact lens breakthrough lets humans see infrared light
29 May, 2025Newly created contact lenses enable infrared vision in both humans and mice by converting infrared light into visible light — which could transform medical imaging and visual assistance technologies.
TGA approves donanemab for treatment of early Alzheimer's
23 May, 2025The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in Australia, while Spanish researchers have presented a new family of candidate compounds for the treatment of Alzheimer's and pain.
Diabetes drug reduces knee arthritis pain in overweight patients
16 May, 2025A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements.
Anti-inflammatory drug may help treat alcohol use disorder
09 May, 2025A drug that is already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity — two issues that commonly co-occur with alcohol use disorder.
Preventing neural graft rejection in Parkinson's patients
01 May, 2025Researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather than attacking them as foreign objects.
Breakthrough drug prevents long COVID symptoms in mice
24 April, 2025Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction — key symptoms of long COVID.
Sleep apnoea patients who use CPAP live longer: study
11 April, 2025CPAP therapy has been found to significantly reduce the risk of death for people with obstructive sleep apnoea (OSA), according to a new meta-analysis.
Human milk harnessed to administer medicine to infants
19 March, 2025The Monash Milk Team are trailblazers in understanding how milk and milk-like systems can be harnessed to enhance oral drug delivery.
